MENU
+Compare
ABVX
Stock ticker: NASDAQ
AS OF
Apr 1 closing price
Price
$5.89
Change
-$0.36 (-5.76%)
Capitalization
415.26M

ABVX Abivax SA Forecast, Technical & Fundamental Analysis

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body’s natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases... Show more

ABVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for ABVX with price predictions
Apr 01, 2025

Aroon Indicator for ABVX shows an upward move is likely

ABVX's Aroon Indicator triggered a bullish signal on March 12, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 34 similar instances where the Aroon Indicator showed a similar pattern. In of the 34 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

The 10-day moving average for ABVX crossed bullishly above the 50-day moving average on March 26, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 2 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ABVX advanced for three days, in of 73 cases, the price rose further within the following month. The odds of a continued upward trend are .

ABVX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The 10-day RSI Indicator for ABVX moved out of overbought territory on March 07, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 6 similar instances where the indicator moved out of overbought territory. In of the 6 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on April 01, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ABVX as a result. In of 24 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for ABVX turned negative on March 28, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 20 similar instances when the indicator turned negative. In of the 20 cases the stock turned lower in the days that followed. This puts the odds of success at .

ABVX moved below its 50-day moving average on March 28, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ABVX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.017) is normal, around the industry mean (13.458). P/E Ratio (0.000) is within average values for comparable stocks, (64.587). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.867). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (192.308) is also within normal values, averaging (251.391).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. ABVX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ABVX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
ABVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ABVX is expected to report earnings to fall 14.29% to -68 cents per share on June 02

Abivax SA ABVX Stock Earnings Reports
Q1'25
Est.
$-0.68
Q4'24
Beat
by $0.50
Q3'24
Beat
by $0.07
Q2'24
Beat
by $0.25
Q4'23
Beat
by $0.08
The last earnings report on March 24 showed earnings per share of -79 cents, beating the estimate of -128 cents. With 216.50K shares outstanding, the current market capitalization sits at 415.26M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
7-11 boulevard Haussmann
Phone
+33 153830963
Employees
24
Web
https://www.abivax.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IMANX14.99N/A
N/A
Iman K
MGNDX43.66N/A
N/A
Praxis Growth Index A
MFRBX46.30N/A
N/A
MFS Research B
IASTX22.06N/A
N/A
Macquarie Asset Strategy Fund Cl R6
NSFHX12.11N/A
N/A
Natixis Target Retirement 2040 N

ABVX and Stocks

Correlation & Price change

A.I.dvisor tells us that ABVX and PHAT have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ABVX and PHAT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABVX
1D Price
Change %
ABVX100%
-2.80%
PHAT - ABVX
31%
Poorly correlated
-5.00%
ZYME - ABVX
28%
Poorly correlated
-3.72%
RGNX - ABVX
28%
Poorly correlated
-8.68%
PLRX - ABVX
27%
Poorly correlated
-8.16%
INZY - ABVX
27%
Poorly correlated
-1.11%
More